Cargando…
“Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!
In the late 1980s, following the human immunodeficiency virus (HIV) epidemic and transfusion-transmitted infections from plasma-derived coagulation factor concentrates to hemophiliacs, many “advanced thinkers” claimed that plasma-derived products would be completely replaced by the year 2000 by safe...
Autores principales: | Burnouf, Thierry, Seghatchian, Jerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106424/ https://www.ncbi.nlm.nih.gov/pubmed/25457750 http://dx.doi.org/10.1016/j.transci.2014.10.002 |
Ejemplares similares
-
Ebola virus convalescent blood products: Where we are now and where we may need to go
por: Burnouf, Thierry, et al.
Publicado: (2014) -
Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products
por: Drew, Victor J., et al.
Publicado: (2018) -
Platelet and extracellular vesicles in COVID-19 infection and its vaccines
por: Goubran, Hadi, et al.
Publicado: (2022) -
SARS-CoV-2 and cancer: the intriguing and informative cross-talk
por: Goubran, Hadi, et al.
Publicado: (2022) -
The Kraepelinian dichotomy – going, going... but still not
gone
por: Craddock, Nick, et al.
Publicado: (2010)